Faculty Advisor

Adams, David S.

Abstract

Phage therapy is the use of viruses to lyse bacteria. The technique has the potential for treating antibiotic-resistant bacterial infections, an increasing threat to our healthcare system. The goal of this IQP project was to evaluate phage therapy technology by assessing its technical, ethical, and regulatory problems, to help determine whether it should be approved for use in the U.S. Our team performed a review of the research literature, and conducted interviews with academic researchers, workers in phage companies, regulatory experts, and bioethicists. We conclude that the technology has great potential, but the methods used need to be standardized, precautions need to be enacted, and more controlled clinical trials need to be performed.

Publisher

Worcester Polytechnic Institute

Date Accepted

August 2016

Project Type

Interactive Qualifying Project

Accessibility

Unrestricted

Advisor Department

Biology and Biotechnology

Share

COinS